Sponsor study identifier
observational
300
1 country
1
Study Start
August 1, 2014
Actual (reported)Primary Completion
July 31, 2019
Actual (reported)Study Completion
July 31, 2019
Actual (reported)We anticipate that drug-naïve ADHD probands, particularly those with DAT1 or SLC6A2 gene variants may have higher level of altered microstructural integrity of frontostriatal (FS), frontoparietal (FP), other hypothesized fiber tracts and decreased brain activity of FS, FP, and other circuits, deficits in ERP, and impaired EF, SA, IIA and VM than probands without DAT1 or SLC6A2 gene variants or adult neurotypical. The alterations in the structural and functional connectivity, neurophysiological and neuropsychological functioning would be observed in the unaffected siblings as compared to neurotypical. The unaffected siblings will be in the intermediate position between drug-naïve adult ADHD probands and neurotypical. The genetic dosage is anticipated to pose the strongest effects on the cortical thickness, brain volume, gyrification and microstructural property of white matter, followed by neurophysiology, functional connectivity, and neuropsychological function with the least effect. In terms of longitudinal follow-up part, we also anticipated despite increasing thinning of cortical thickness, microstructural integrity of several targets fiber tracts, and brain activity of target brain regions and improving performance in EF, SA, IIV, VM from childhood to late adolescence and young adulthood in the neurotypical group, the slopes of developmental trajectories of these neuroimaging and neuropsychological function are lower in the ADHD group.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 31, 2019
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 1, 2014
Actual (reported)August 25, 2014
Actual (reported)December 30, 2015
Actual (reported)July 31, 2019
Actual (reported)July 31, 2019
Actual (reported)Structural neuroimaging
Using diffusing spectrum imaging (DSI) to assess the structural connectivity in frontostriatal, frontoparietal and other circuitries
1 day
Functional connectivity of the brain circuits
1 day
Drug-naïve adult ADHD Probands
Unaffected Siblings of Drug-naïve Adult ADHD
Age-, sex-, handedness-, and IQ-matched controls without lifetime ADHD or a family history of ADHD
This 5-year proposal consists of two parts: (1) a 3-year case-control study with unaffected siblings and adult neurotypicals as controls to investigate the brain structural connectivity, functional connectivity, neurophysiological, neuropsychological functioning in 60 probands with ADHD, their unaffected siblings (at least 30 same-sex siblings, n=30\~60) and age-, sex-, handedness-, and IQ-matched neurotypicals (n=90\~120) with estimated total sample size as at least 180 up to 240. (2) a 2-year follow-up study to repeat the neuropsychological and MRI assessments and to assess electrophysiology related to inhibition controls of 40 adolescents and young adults with childhood diagnosis of ADHD and 40 neurotypicals who had same neuropsychological and imaging assessments in 2010.8-1013.7.
National Taiwan Univeristy Hospital
Taipei, Taiwan
Chang JC, Lin HY, Gau SS. Age-dependent effects of cumulative methylphenidate exposure on brain structure and symptom amelioration in youth with ADHD: A longitudinal MRI study. Prog Neuropsychopharmacol Biol Psychiatry. 2025 Jul 13;140:111429. doi: 10.1016/j.pnpbp.2025.111429. Epub 2025 Jun 15.
Lee CY, Goh JOS, Gau SS. Differential neural processing of value during decision-making in adults with attention-deficit/hyperactivity disorder and healthy controls. J Psychiatry Neurosci. 2023 Mar 29;48(2):E115-E124. doi: 10.1503/jpn.220123. Print 2023 Mar-Apr.
The subjects will receive blood withdrawal. The blood sample will be used for establishing lymphoblastoid cell lines, which will be used for molecular genetic experiments
Susan Shur-Fen Gau, MD, PhD
National Taiwan University Hospital & College of Medicine
300 participants (actual enrollment reported by the registry).
First Submitted
August 25, 2014
First Posted
December 30, 2015
Study Start
August 1, 2014
Actual (reported)A Longitudinal Follow-up Study of Neuroimage and Neuropsychological Endophenotype Study on ADHD
Contact the study team to confirm eligibility.
Primary Completion
July 31, 2019
Actual (reported)Study Completion
July 31, 2019
Actual (reported)Last Updated
September 2, 2021
Record last verified: 2021-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: